NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
83 hedge funds and large institutions have $100M invested in Navidea Biopharmaceuticals Inc. in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
79% less call options, than puts
Call options by funds: $2.6M | Put options by funds: $12.2M
Holders
83
Holding in Top 10
1
Calls
$2.6M
Puts
$12.2M
Top Buyers
| 1 | +$10.1M | |
| 2 | +$6.84M | |
| 3 | +$4.63M | |
| 4 |
IG
ING Group
Amsterdam,
Netherlands
|
+$2.23M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$1.31M |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$1.03M | |
| 3 | -$302K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$228K |
| 5 |
BL
Bolton LP
Greenwich,
Connecticut
|
-$160K |